Iktos
Eleonora Echegaray is an accomplished professional in marketing and communications, currently serving as the Marketing & Communications Director at iktos since September 2024. Prior to this role, Eleonora held various positions at Elsevier from July 2016 to September 2024, including Director of Life Sciences Portfolio Marketing and Head of Chemistry Solution Marketing, where significant contributions were made to executive steering and strategic planning for the launch of New Reaxys. Earlier experience includes serving as Business Development Director for European Markets at Swissaustral Biotech SA, leveraging a strong background in chemistry to address technical challenges in the Pharmaceutical and Chemical industries. Eleonora's educational credentials include a Master's degree in Management, Technology and Entrepreneurship from EPFL, a Master's in Chemistry from Pontificia Universidad Católica de Chile, and doctoral studies in Computational Chemistry from the same institution, supplemented by a visiting PhD program at McMaster University.
This person is not in any teams
This person is not in any offices
Iktos
Incorporated in October 2016, Iktos is a start-up company specializing in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existingdata, the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as a professional services and as a SaaS software platform. Iktos offers Makya™, ligand and structure-based de novo drug design platform for multi-parametric optimisation (MPO) of lead compounds in line with Target Candidate Profile (TCP). Iktos is also developing Spaya™, a synthesis planning software based upon Iktos’s proprietary AI technology for retrosynthesis.